Surrogate endpoints included recurrence, lymph node metastasis, and epithelial–mesenchymal transition, as demonstrated for miR-1307-5p [47] and transgelin mRNA/miR-145-5p [49]. The gene discussed is TAGLN; the disease is metastatic malignant neoplasm in the lymph nodes.